0001949258-22-000001.txt : 20221005 0001949258-22-000001.hdr.sgml : 20221005 20221005122200 ACCESSION NUMBER: 0001949258-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221005 DATE AS OF CHANGE: 20221005 EFFECTIVENESS DATE: 20221005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nurture Genomics, Inc. CENTRAL INDEX KEY: 0001949258 IRS NUMBER: 881628016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460778 FILM NUMBER: 221294979 BUSINESS ADDRESS: STREET 1: CAMBRIDGE INNOVATION CENTER, 1 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6179663216 MAIL ADDRESS: STREET 1: CAMBRIDGE INNOVATION CENTER, 1 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001949258 Nurture Genomics, Inc. CAMBRIDGE INNOVATION CENTER, 1 BROADWAY CAMBRIDGE MA MASSACHUSETTS 02142 6179663216 DELAWARE None None Corporation true 2022 Hans Keil Cambridge Innovation Center One Broadway, Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Robert C Green Cambridge Innovation Center One Broadway, Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Director David Feinberg Cambridge Innovation Center One Broadway, Kendall Square Cambridge MA MASSACHUSETTS 02142 Executive Officer Other Health Care Decline to Disclose 06b false 2022-09-23 false true true true Simple Agreement for Future Equity false 0 3000000 355000 2645000 false 5 0 0 200000 true Sale will be used to fund the development of the Company, which heretofore has been funded personally by one or more persons listed in Item 3. A portion of such proceeds (not to exceed 10% of the offering) may be applied to reimbursing such persons. false Nurture Genomics, Inc. /s/ Hans Keil Hans Keil Chief Executive Officer 2022-10-05